4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one

C166H176N24O21 — CID 157069004

IUPAC4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one
SMILESC=C1CCC(N2Cc3c(OCc4ccc(CN5CCc6ccccc65)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(Cn5cc(C(N)=O)nn5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(Cn5ccnc5C)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cccc(CN5CCC(C(C)C)CC5)c4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cccc(CN5CCC(c6ccccc6)CC5)c4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4nc(CN5CCOCC5)no4)cccc3C2=O)C(=O)N1
InChIInChI=1S/C33H35N3O3.C30H29N3O3.C30H37N3O3.C26H26N4O3.C25H24N6O4.C22H25N5O5/c1-23-13-14-30(32(37)34-23)36-21-29-28(33(36)38)11-6-12-31(29)39-22-25-8-5-7-24(19-25)20-35-17-15-27(16-18-35)26-9-3-2-4-10-26;1-20-9-14-27(29(34)31-20)33-18-25-24(30(33)35)6-4-8-28(25)36-19-22-12-10-21(11-13-22)17-32-16-15-23-5-2-3-7-26(23)32;1-20(2)24-12-14-32(15-13-24)17-22-6-4-7-23(16-22)19-36-28-9-5-8-25-26(28)18-33(30(25)35)27-11-10-21(3)31-29(27)34;1-17-6-11-23(25(31)28-17)30-15-22-21(26(30)32)4-3-5-24(22)33-16-20-9-7-19(8-10-20)14-29-13-12-27-18(29)2;1-15-5-10-21(24(33)27-15)31-12-19-18(25(31)34)3-2-4-22(19)35-14-17-8-6-16(7-9-17)11-30-13-20(23(26)32)28-29-30;1-14-5-6-17(21(28)23-14)27-11-16-15(22(27)29)3-2-4-18(16)31-13-20-24-19(25-32-20)12-26-7-9-30-10-8-26/h2-12,19,27,30H,1,13-18,20-22H2,(H,34,37);2-8,10-13,27H,1,9,14-19H2,(H,31,34);4-9,16,20,24,27H,3,10-15,17-19H2,1-2H3,(H,31,34);3-5,7-10,12-13,23H,1,6,11,14-16H2,2H3,(H,28,31);2-4,6-9,13,21H,1,5,10-12,14H2,(H2,26,32)(H,27,33);2-4,17H,1,5-13H2,(H,23,28)
InChIKeyACEZVJLUJKLLLI-UHFFFAOYSA-N
MW2843.38 g/mol
LogP21.40
Rot. Bonds39

About 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one

4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one (PubChem CID 157069004) has the molecular formula C166H176N24O21 and a molecular weight of 2843.38 g/mol. Its IUPAC name is 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one.

Molecular Properties

Compound Name4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one
PubChem CID157069004
Molecular FormulaC166H176N24O21
Molecular Weight2843.38 g/mol
Exact Mass2841.34
IUPAC Name4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one
SMILESC=C1CCC(N2Cc3c(OCc4ccc(CN5CCc6ccccc65)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(Cn5cc(C(N)=O)nn5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(Cn5ccnc5C)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cccc(CN5CCC(C(C)C)CC5)c4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cccc(CN5CCC(c6ccccc6)CC5)c4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4nc(CN5CCOCC5)no4)cccc3C2=O)C(=O)N1
InChIInChI=1S/C33H35N3O3.C30H29N3O3.C30H37N3O3.C26H26N4O3.C25H24N6O4.C22H25N5O5/c1-23-13-14-30(32(37)34-23)36-21-29-28(33(36)38)11-6-12-31(29)39-22-25-8-5-7-24(19-25)20-35-17-15-27(16-18-35)26-9-3-2-4-10-26;1-20-9-14-27(29(34)31-20)33-18-25-24(30(33)35)6-4-8-28(25)36-19-22-12-10-21(11-13-22)17-32-16-15-23-5-2-3-7-26(23)32;1-20(2)24-12-14-32(15-13-24)17-22-6-4-7-23(16-22)19-36-28-9-5-8-25-26(28)18-33(30(25)35)27-11-10-21(3)31-29(27)34;1-17-6-11-23(25(31)28-17)30-15-22-21(26(30)32)4-3-5-24(22)33-16-20-9-7-19(8-10-20)14-29-13-12-27-18(29)2;1-15-5-10-21(24(33)27-15)31-12-19-18(25(31)34)3-2-4-22(19)35-14-17-8-6-16(7-9-17)11-30-13-20(23(26)32)28-29-30;1-14-5-6-17(21(28)23-14)27-11-16-15(22(27)29)3-2-4-18(16)31-13-20-24-19(25-32-20)12-26-7-9-30-10-8-26/h2-12,19,27,30H,1,13-18,20-22H2,(H,34,37);2-8,10-13,27H,1,9,14-19H2,(H,31,34);4-9,16,20,24,27H,3,10-15,17-19H2,1-2H3,(H,31,34);3-5,7-10,12-13,23H,1,6,11,14-16H2,2H3,(H,28,31);2-4,6-9,13,21H,1,5,10-12,14H2,(H2,26,32)(H,27,33);2-4,17H,1,5-13H2,(H,23,28)
InChIKeyACEZVJLUJKLLLI-UHFFFAOYSA-N
XLogP21.40
TPSA504.57 Ų
H-Bond Donors7
H-Bond Acceptors32
Rotatable Bonds39
Heavy Atoms211
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002843.38
LogP ≤ 521.40
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1032

Analyze 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[7-[[4-(7,8-dihydro-5H-1,6-naphthyridin-6-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;2-[[4-[[2-[(1S)-2,4-dioxocyclohexyl]-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]-3,4-dihydro-1H-isoquinoline-7-carbonitrile;4-[7-[[4-[(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(2-methyl-4-phenylimidazol-1-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]-1,2-oxazol-5-yl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[2-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione
CID 157235956
4-[7-[[4-[[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-(7,8-dihydro-5H-1,6-naphthyridin-6-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]-1,2-oxazol-5-yl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[2-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione
CID 157610600
4-[7-[[4-(7,8-dihydro-5H-1,6-naphthyridin-6-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(2-methyl-4-phenylimidazol-1-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]-1,2-oxazol-5-yl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[2-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione
CID 158115808
2-(2,4-dioxocyclohexyl)-4-[[4-[[2-(trifluoromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione;4-[7-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[(4-pyridin-2-ylpyridin-1-ium-1-yl)methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;formate
CID 158234626
bis(3-[7-[[4-[(4-tert-butyltriazol-1-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione);3-[7-[[4-(1,3-dihydroisoindol-2-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione;formic acid;(3S)-3-[7-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione;3-[3-oxo-7-[[4-[[(2S)-2-(trifluoromethyl)pyrrolidin-1-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]piperidine-2,6-dione;3-[3-oxo-7-[[4-[(2,4,5-trimethylimidazol-1-yl)methyl]phenyl]methoxy]-1H-isoindol-2-yl]piperidine-2,6-dione
CID 158576578
formic acid;4-[7-[[4-[(4-methylmorpholin-4-ium-4-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[(4-pyridin-2-ylpyridin-1-ium-1-yl)methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;formate
CID 158660308
2-[[4-[[2-[(1S)-2,4-dioxocyclohexyl]-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]-3,4-dihydro-1H-isoquinoline-7-carbonitrile;formic acid;4-[7-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(2-methyl-4-phenylimidazol-1-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(4-oxidomorpholin-4-ium-4-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione
CID 160302394
9-[[2-[2-(2,4-dioxocyclohexyl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]-N-ethyl-4-oxononanamide;2-(2,6-dioxopiperidin-3-yl)-4-[[5-(2-ethoxyethoxy)-2-oxopentyl]amino]isoindole-1,3-dione;N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzamide;1-[3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylphenyl]-2-[4-[(4-propylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]ethanone
CID 161115623
4-[7-[[3-[[4-(1-aminoethyl)piperidin-1-yl]methyl]-1,2-oxazol-5-yl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-(7,8-dihydro-5H-1,6-naphthyridin-6-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[2-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione
CID 161332222
formic acid;4-[7-[[4-[(4-hydroxymorpholin-4-ium-4-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[(4-pyridin-2-ylpyridin-1-ium-1-yl)methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;formate
CID 161505616
2-[[4-[[2-[(1S)-2,4-dioxocyclohexyl]-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]-3,4-dihydro-1H-isoquinoline-7-carbonitrile;4-[7-[[4-[(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(2-methyl-4-phenylimidazol-1-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]-1,2-oxazol-5-yl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[2-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione
CID 161897233
4-[7-[[4-(7,8-dihydro-5H-1,6-naphthyridin-6-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[7-[[4-[(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]-1,2-oxazol-5-yl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione;4-[3-oxo-7-[[4-[[2-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]methyl]phenyl]methoxy]-1H-isoindol-2-yl]cyclohexane-1,3-dione
CID 168405361

Frequently Asked Questions

What is the IUPAC name of 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
The IUPAC name of 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one (CID 157069004) is 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one.
What is the SMILES notation for 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
The canonical SMILES for 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one is C=C1CCC(N2Cc3c(OCc4ccc(CN5CCc6ccccc65)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(Cn5cc(C(N)=O)nn5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(Cn5ccnc5C)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cccc(CN5CCC(C(C)C)CC5)c4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cccc(CN5CCC(c6ccccc6)CC5)c4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4nc(CN5CCOCC5)no4)cccc3C2=O)C(=O)N1.
What is the InChIKey of 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
The InChIKey is ACEZVJLUJKLLLI-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H35N3O3.C30H29N3O3.C30H37N3O3.C26H26N4O3.C25H24N6O4.C22H25N5O5/c1-23-13-14-30(32(37)34-23)36-21-29-28(33(36)38)11-6-12-31(29)39-22-25-8-5-7-24(19-25)20-35-17-15-27(16-18-35)26-9-3-2-4-10-26;1-20-9-14-27(29(34)31-20)33-18-25-24(30(33)35)6-4-8-28(25)36-19-22-12-10-21(11-13-22)17-32-16-15-23-5-2-3-7-26(23)32;1-20(2)24-12-14-32(15-13-24)17-22-6-4-7-23(16-22)19-36-28-9-5-8-25-26(28)18-33(30(25)35)27-11-10-21(3)31-29(27)34;1-17-6-11-23(25(31)28-17)30-15-22-21(26(30)32)4-3-5-24(22)33-16-20-9-7-19(8-10-20)14-29-13-12-27-18(29)2;1-15-5-10-21(24(33)27-15)31-12-19-18(25(31)34)3-2-4-22(19)35-14-17-8-6-16(7-9-17)11-30-13-20(23(26)32)28-29-30;1-14-5-6-17(21(28)23-14)27-11-16-15(22(27)29)3-2-4-18(16)31-13-20-24-19(25-32-20)12-26-7-9-30-10-8-26/h2-12,19,27,30H,1,13-18,20-22H2,(H,34,37);2-8,10-13,27H,1,9,14-19H2,(H,31,34);4-9,16,20,24,27H,3,10-15,17-19H2,1-2H3,(H,31,34);3-5,7-10,12-13,23H,1,6,11,14-16H2,2H3,(H,28,31);2-4,6-9,13,21H,1,5,10-12,14H2,(H2,26,32)(H,27,33);2-4,17H,1,5-13H2,(H,23,28).
What are the key properties of 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one has a molecular weight of 2843.38 g/mol, XLogP of 21.40, 39 rotatable bonds, 7 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[4-(2,3-dihydroindol-1-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylimidazol-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]-3H-isoindol-1-one;1-[[4-[[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]triazole-4-carboxamide;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-phenylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[3-[(4-propan-2-ylpiperidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one is sourced from PubChem (CID 157069004), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).